News

Using a discovery platform whose components range from yeast cells to human stem cells, scientists have identified a novel Parkinson’s disease drug target.

Findings further creation of regenerative therapies for humans.

Could speed mass intervention in developing countries.

Currently, disease usually found too late to save lives.

An international study has uncovered 11 new genes that increase the chance of developing Alzheimer’s disease and provide new clues to ways of fighting it.

SIGMA 2 is aimed at harnessing genomic medicine for the benefit of Latin America and the world.

In many types of cancer, standard chemotherapy cures only a fraction of patients.

Some gut bacterial strains are specifically adapted to use sugars in our gut lining to aid colonisation, potentially giving them a major influence over our gut health.

DSM Pharmaceutical Products officially opens its new cGMP facility for biopharmaceutical contract manufacturing in Brisbane, Australia.

Vogelbusch technology beats emission standards and allows best-of-breed performance.